GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Sale Of Property, Plant, Equipment

Biomics Biopharma (ASX:BBM) Sale Of Property, Plant, Equipment : A$ Mil (TTM As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma Sale Of Property, Plant, Equipment?

Biomics Biopharma's sale of property, plant, equipment for the six months ended in . 20 was A$0.00 Mil. It means Biomics Biopharma gained A$0.00 Mil from selling property, plant, and equipment.

Compared with last quarter (A$0.00 Mil in . 20 ), Biomics Biopharma gained the same money from selling property, plant, and equipment in . 20 (A$0.00 Mil).


Biomics Biopharma Sale Of Property, Plant, Equipment Historical Data

The historical data trend for Biomics Biopharma's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma Sale Of Property, Plant, Equipment Chart

Biomics Biopharma Annual Data
Trend
Sale Of Property, Plant, Equipment

Biomics Biopharma Semi-Annual Data
Sale Of Property, Plant, Equipment

Biomics Biopharma Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.


Biomics Biopharma Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Biomics Biopharma's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomics Biopharma (ASX:BBM) Business Description

Industry
Traded in Other Exchanges
N/A
Address
1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000
Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines